K

KaloCyte, Inc.

14 employees

Kalocyte provides red blood cell substitutes used for trauma care related services.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Emergency Medicine
Health Care
RBC Physiology
Trauma Care
Nanotechnology
Startup

Date founded

2016

Funding rounds raised

Total raised

$800K

from 2 investors over 2 rounds

K

KaloCyte, Inc. raised $300K on June 8, 2020

Investors: Maryland Momentum Fund

K

KaloCyte, Inc. raised $800K on June 5, 2018

Investors: St. Louis Arch Angels

FAQ